Charlotte DiStefano, PhD
June 24, 2020

EEG Biomarkers of Language in Angelman Syndrome

$200,000 The goal of this study is to establish biomarkers of language function in Angelman syndrome. Language is a likely target for both behavioral and pharmaceutical treatment, as it represents a core deficit in Angelman syndrome and is a major […]

Read more
Margaret Bradley
January 23, 2020

Brain potentials of cognition and emotion in AS

$35,000 We know that individuals with AS have a propensity for a happy demeanor and often have excessive laughter. We also know that they have pro-social behaviors that are distinctive from other types of genetic conditions. This study evaluated older […]

Read more
December 14, 2019

Validation of biomarkers for Angelman syndrome clinical trials

Ben Philpot, Ph.D. – University of North Carolina-Chapel Hill Heather Hazlett, Ph.D. – Carolina Institute of Developmental Disabilities at University of North Carolina-Chapel Hill Ron Thibert, M.D. – Massachusetts General Hospital $295,970 (2 years) This unique research project is the […]

Read more